Syndax Pharmaceuticals Inc (SNDX) 8-K Current Report — February 26, 2026
Filed: February 26, 2026
Health Care
Pharmaceutical PreparationsSyndax Pharmaceuticals Inc (SNDX) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
Syndax Pharmaceuticals Inc 8-K Feb 26, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q1 2025 earnings press release referenced via exhibit — full financial results in accompanying exhibit, not inline text
- • Boilerplate language confirms results disclosure is Reg FD-compliant but not incorporated by reference into SEC filings
Get deeper insights on Syndax Pharmaceuticals Inc
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.